Opportunities and limitations of natural killer cells as adoptive therapy for malignant disease

Area of Science:

• Immunology
• Cell Biology
• Cancer Therapy

Background:

• Natural killer (NK) cells are crucial for innate immunity and cancer surveillance.
• Current techniques allow for NK cell generation for adoptive therapy, but efficacy varies.
• NK cell function is regulated by a balance of activating and inhibitory cell-surface receptors.

Purpose of the Study:

• To explore strategies for optimizing NK cell function in adoptive immunotherapy.
• To highlight the importance of balancing activating and inhibitory signals for anti-tumor activity.
• To inform the design of novel NK cell-based cancer treatment strategies.

Main Methods:

• Analysis of the balance between activating and inhibitory signals in NK cell function.
• Selection of NK cells with a predominant activating profile.
• Investigating methods like killer immunoglobulin-like receptor (KIR)-mismatched NK cell donation and blocking inhibitory pathways.
• Exploring NK cell licensing or priming with tumor cells.

Main Results:

• Individual differences in NK cell function significantly impact therapeutic efficacy.
• A predominant activating profile in NK cells is critical for successful anti-tumor activity.
• KIR-mismatched NK donors and blocking inhibitory pathways can enhance NK cell selection.
• NK cell licensing/priming may be necessary for optimal cytotoxicity.

Conclusions:

• Optimizing NK cell adoptive transfer for malignancies necessitates understanding the balance of activating and inhibitory signals.
• Strategies focusing on selecting potent NK cells and enhancing their cytotoxic potential are vital.
• Recent advances in NK cell biology provide a foundation for developing improved adjuvant therapies to maximize anti-tumor efficacy.